AI assistant
Sending…
X4 Pharmaceuticals, Inc — Director's Dealing 2019
Mar 15, 2019
34355_dirs_2019-03-14_8a76b7b5-d5d8-4ac7-a2a5-4afb8d19a572.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2019-03-13
Reporting Person: Ragan Paula (Director, President and CEO)
More from X4 Pharmaceuticals, Inc
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 20
Remuneration Information
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17